Biovista announced recently that it has entered into a research collaboration agreement with Novartis.
Browsing: Uncategorized
Bio-Path Holdings has developed a powerful drug delivery technology that utilizes cell-like drug carriers, termed liposomes, which avoid drug breakdown.
Parting is such sweet sorrow when building a company from infancy and then letting go to see it spread its wings. Planning a proper exit strategy is crucial and not just when referring to love and war.
ADVENTRX and SynthRx, a private biotechnology company, completed a definitive merger on April 8, 2011.
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
Women should be aware that they have several options for colon cancer screening, and not only the often-dreaded colonoscopy, according to a new report from the American College of Obstetricians and Gynecologists.
EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.
Exosome Diagnostics is a specialized bio-pharmaceutical company that develops a unique kind of genetic-based diagnostic tests. The company’s technological platform isolates from the blood micro-vesicles produced by cells, and then analyze the genetic material in the vesicles, which is representative of the cells they were made from. Certain cells, such as cancer cells, contain a genetic signature and therefore isolation of vesicles containing this genetic material is indicative of the disease. In particular, cancer cells have been shown to produce a large amount of micro-vesicles (or exosomes) and therefore this technology can serve to identify hard to detect cancer cases.…